{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:22Z","timestamp":1761630382919,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":3378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1111\/j.1469-0691.2005.01215.x","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T12:25:54Z","timestamp":1123244754000},"page":"736-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients"],"prefix":"10.1016","volume":"11","author":[{"given":"I.D.","family":"Pavlopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.Ph.","family":"Syriopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chelioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Daikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Stamatiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kostakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.N.","family":"Boletis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2005.01215.x_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients","volume":"13","author":"Sia","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Cytogam, MedImmune, Inc., Gaithersburg, Maryland","volume":"103","author":"George","year":"1997","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0272-6386(97)90205-5","article-title":"The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation","volume":"29","author":"Schnitzler","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00007890-199306000-00013","article-title":"The cost impact of cytomegalovirus disease in renal transplant recipients","volume":"55","author":"McCarthy","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib5","series-title":"Clinical nephrology, dialysis and transplantation","first-page":"1","article-title":"Infectious complications in renal transplantation","author":"Brennan","year":"1999"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08820139709048930","article-title":"Management of cytomegalovirus infection in solid organ transplant recipients","volume":"26","author":"Murray","year":"1997","journal-title":"Immunol Invest"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM199609053351007","article-title":"Ganciclovir","volume":"335","author":"Crumpacker","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/342385","article-title":"Ganciclovir-resistant cytomegalovirus in organ transplant recipients","volume":"35","author":"Limaye","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib10","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mcp.2002.126306","article-title":"Pharmacokinetics of valganciclovir and ganciclovir in renal impairment","volume":"72","author":"Czock","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM198905253202105","article-title":"A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts","volume":"320","author":"Balfour","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib13","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/00007890-199812270-00019","article-title":"A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"66","author":"Flechner","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2165\/00003495-199652050-00009","article-title":"Valacyclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections","volume":"52","author":"Perry","year":"1996","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib16","series-title":"Clinical transplants 2000","first-page":"363","article-title":"Renal transplantation in Greece","author":"Kostakis","year":"2000"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-3542(95)00066-6","article-title":"Valacyclovir: a review of its antiviral activity, pharmacokinetic properties and clinical efficacy","volume":"28","author":"Beutner","year":"1995","journal-title":"Antiviral Res"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1432-2277.2002.tb00120.x","article-title":"A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation","volume":"15","author":"Reischig","year":"2002","journal-title":"Transplant Int"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ndt\/gfg039","article-title":"Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients","volume":"18","author":"Yango","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib21","first-page":"462","article-title":"Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis","volume":"10","author":"Couchoud","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1600-6143.2004.00451.x","article-title":"Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00019053-200018030-00004","article-title":"Costeffectiveness model of cytomegalovirus management strategies in renal transplantation: comparing valaciclovir prophylaxis with current practice","volume":"18","author":"Mauskopf","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib24","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00007890-200011270-00012","article-title":"Valacyclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation","volume":"70","author":"Legendre","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0041-1345(98)00256-5","article-title":"Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients","volume":"30","author":"Conti","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1399-0012.2000.140303.x","article-title":"Failure of ganciclovir prophylaxis to completely eradicate CMV disease in renal transplant recipients treated with intense anti-rejection immunotherapy","volume":"14","author":"Isenberg","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ndt\/15.5.711","article-title":"The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infection and disease after renal transplantation","volume":"15","author":"ter Meulen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jmv.10549","article-title":"Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients","volume":"72","author":"Goossens","year":"2004","journal-title":"J Med Virol"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/AAC.42.2.216","article-title":"The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir and penciclovir in vitro and in vivo","volume":"42","author":"Neyts","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1086\/318724","article-title":"Prevention of cytomegalovirus disease in recipients of solid-organ transplants","volume":"32","author":"Paya","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib31","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.140123497","article-title":"Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy","volume":"181","author":"Emery","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00007890-199808150-00008","article-title":"Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood","volume":"66","author":"Baldanti","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/00007890-199705270-00031","article-title":"Failure of ganciclovir treatment associated with selection of a ganciclovir resistant cytomegalovirus strain in a lung transplant recipient","volume":"63","author":"Alain","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007890-199702150-00026","article-title":"Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation","volume":"63","author":"Rosen","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jmv.20127","article-title":"Detection of ganciclovir resistance after valacyclovir prophylaxis in renal transplant recipients with active cytomegalovirus infection","volume":"73","author":"Alain","year":"2004","journal-title":"J Med Virol"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib37","series-title":"Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans","first-page":"202","article-title":"Acyclovir and valacyclovir prophylaxis of AIDS patients does not alter cytomegalovirus susceptibility to ganciclovir or foscarnet [abstract 15]","author":"Weinberg","year":"1996"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1399-0012.2004.00180.x","article-title":"Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas\u2013kidney, and pancreas transplantation","volume":"18","author":"Ciancio","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-3062.2004.00066.x","article-title":"Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease","volume":"6","author":"Taber","year":"2004","journal-title":"Transplant Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/425905","article-title":"Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir","volume":"191","author":"Mattes","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib41","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1086\/382753","article-title":"Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients","volume":"189","author":"Boivin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01215.x_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14623806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14623806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:15:28Z","timestamp":1761117328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14623806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1198743X14623806"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01215.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01215.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}